Somerville Kurt F Amgen Inc Transaction History

Somerville Kurt F

$582 Million
Q2 2024

A detailed history of Somerville Kurt F transactions in Amgen Inc stock. As of the latest transaction made, Somerville Kurt F holds 1,202 shares of AMGN stock, worth $383,702. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,202

Previous 1,202 -0.0%

Holding current value

$383,702

Previous $341,000 9.97%

% of portfolio

0.06%

Previous 0.06%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $332,410 - $374,998	-1,300 Reduced 51.96%	1,202 $346,000
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $27,331 - $33,932	-125 Reduced 4.76%	2,502 $672,000
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $4,351 - $5,529	-19 Reduced 0.72%	2,627 $689,000
Q3 2022 Nov 08, 2022	SELL	$224.46 - $253.15 $11,223 - $12,657	-50 Reduced 1.85%	2,646 $596,000
Q2 2022 Jul 19, 2022	BUY	$230.71 - $256.74 $28,838 - $32,092	125 Added 4.86%	2,696 $655,000
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $102,078 - $118,956	-460 Reduced 15.18%	2,571 $640,000
Q1 2020 May 07, 2020	BUY	$182.24 - $241.7 $89,297 - $118,433	490 Added 19.28%	3,031 $615,000
Q2 2019 Jul 24, 2019	SELL	$166.7 - $195.41 $64,179 - $75,232	-385 Reduced 13.16%	2,541 $468,000
Q4 2018 Jan 24, 2019	SELL	$178.4 - $208.25 $1,784 - $2,082	-10 Reduced 0.34%	2,926 $570,000
Q3 2018 Oct 15, 2018	BUY	$185.29 - $208.89 $64,851 - $73,111	350 Added 13.53%	2,936 $608,000
Q2 2018 Jul 30, 2018	SELL	$166.05 - $186.51 $4,151 - $4,662	-25 Reduced 0.96%	2,586 $477,000
Q1 2018 Apr 24, 2018	SELL	$169.43 - $198.0 $4,235 - $4,950	-25 Reduced 0.95%	2,611 $445,000
Q4 2017 Feb 02, 2018	SELL	$168.79 - $188.59 $4,219 - $4,714	-25 Reduced 0.94%	2,636 $459,000
Q3 2017 Oct 26, 2017	BUY	$167.29 - $191.0 $445,158 - $508,251	2,661	2,661 $495,000

Others Institutions Holding AMGN

# of Institutions

3,084

Shares Held

417M

Call Options Held

7.18M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Somerville Kurt F, based on Form 13F filings with the SEC.

News

Stay updated on Somerville Kurt F with notifications on news.

Account

Somerville Kurt F Amgen Inc Transaction History